FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/SNY
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Sanofi SA (SNY) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Sanofi (SNY) trades at $44.34, up 2.81% with strong earnings momentum as the company has beaten EPS estimates for four consecutive quarters. The stock shows bullish technical signals with positive moving averages, though RSI levels suggest potential overbought conditions. Recent expansion of the immunology alliance with Regeneron, valued up to $8 billion, highlights strategic growth initiatives beyond the blockbuster Dupixent franchise.
The outlook remains positive with revenue growth and margin expansion, though investors face risks from patent expirations and competitive pressures. Analyst consensus leans neutral with 44% buy ratings, while institutional sentiment is balanced between technical strength and valuation considerations amid ongoing pipeline development.
Read full analysis

Key Stats

  • Market Cap
    $106.83B
  • Volume
    15,100,460
  • Sector
    Health
  • 52W High
    $52.34
  • 52W Low
    $39.12
  • Typical Hold Time
    95 Days
  • Enterprise Value
    $122.35B
  • Div Yield
    5.45%
  • Trading Activity
    -
$44.34
52W Low: $39.12
13 Oct 2026
52W High: $52.34
13 Nov 2025

Track Sanofi SA (SNY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Sanofi SA has traded between a low of $39.12 and a high of $52.34, highlighting its annual price range. Buy and sell Sanofi SA shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Most Recent News

Content is generated by Aura AI

Anteris reports positive 30-day results for Medium-size DurAVR heart valve in severe aortic stenosis patients

Anteris Technologies announced favorable 30-day clinical outcomes for its Medium-size DurAVR Transcatheter Heart Valve (THV) in 22 patients with severe aortic stenosis. The valve showed excellent hemodynamics with low pressure gradients, large effect...

Market News
2 hours ago
Na
Bullish
news icon
Anteris reports positive 30-day results for Medium-size DurAVR heart valve in severe aortic stenosis patients

CT-guided PCI matches IVUS outcomes with faster procedures and less contrast, changing treatment plans in 70% of cases.

A landmark P4 randomized trial showed that CT-guided percutaneous coronary intervention (PCI) delivers clinical outcomes comparable to the gold-standard intravascular ultrasound (IVUS) at one year, while reducing procedure time by 27% and contrast us...

Market News
3 hours ago
Heartflow, Inc.
Bullish
news icon
CT-guided PCI matches IVUS outcomes with faster procedures and less contrast, changing treatment plans in 70% of cases.

OpenAI plans PR push post-midterms, rebranding data centers as 'AI compute campuses' to shape AI debate.

OpenAI is preparing a public relations campaign after the U.S. midterm elections, anticipating Democrats may regain control of Congress. The company aims to influence the future AI policy debate, including proposals like AI "speed limits" and global ...

Market News
5 hours ago
TechCrunch
Neutral
OpenAI plans PR push post-midterms, rebranding data centers as 'AI compute campuses' to shape AI debate.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $106.83B
  • Volume
    15,100,460
  • Sector
    Health
  • 52W High
    $52.34
  • 52W Low
    $39.12
  • Typical Hold Time
    95 Days
  • Enterprise Value
    $122.35B
  • Div Yield
    5.45%
  • Trading Activity
    -
$44.34
52W Low: $39.12
13 Oct 2026
52W High: $52.34
13 Nov 2025

Track Sanofi SA (SNY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Sanofi SA has traded between a low of $39.12 and a high of $52.34, highlighting its annual price range. Buy and sell Sanofi SA shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!